Open Access Research Article Article ID: AOT-1-102

    College of American Pathologists EQAS for Luminex Antibody Test in a Stand -Alone Accredited Indian Laboratory

    Mahendra Narain Mishra* and Vandana Lal

    Luminex antibody detection, especially Luminex crossmatch is used frequently in India for pretransplant work up for patients with end stage renal disease. This test is often performed in lieu of single antigen bead assay in India due to its lower cost. We report on our experience with College of American Pathologist external proficiency test samples (CAP EQAS) for Luminex based antibody detection assays.

    Methods: Twelve surveys from College of American Pathologists (MX-1 A, B, C) each comprising of either four plasma samples for HLA – class I, two samples for HLA – class II (MX- 2 A, B and C) and two sets of whole blood containing non enriched lymphocytes were processed as per schedule from January 2014 till December 2014 for detection of HLA class I or/and HLA class II IgG antibodies. 

    Results: All six surveys were fully concordant for antibody screening which is a pooled bead assay: greater than ninety percent samples of phenotype test were accurately assigned, but six samples (16.67%) of Luminex T cell crossmatch were discordant of which five samples were incorrectly assigned negative possibly due to matrix interference. 

    Conclusion: CAP EQAS survey was adequate for external quality control of Luminex antibody assays except for Luminex crossmatch test. This could be due to matrix interference and such discordant results need to be correlated by inter-lab comparison until CAP is able to provide suitable samples.

    Keywords: Luminex; Antibody; College of american pathologists; External proficiency test

    Published on: Nov 30, 2016 Pages: 22-23

    Full Text PDF Full Text HTML DOI: 10.17352/aot.000002
    Get Citation Base Search Scilit OAI-PMH ResearchGate GrowKudos CrossMark

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on AOT